Market Cap 182.46M
Revenue (ttm) 0.00
Net Income (ttm) -47.05M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.73
Volume 301,400
Avg Vol 544,556
Day's Range N/A - N/A
Shares Out 64.47M
Stochastic %K 61%
Beta 1.03
Analysts Sell
Price Target $11.00

Company Profile

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the drug research and development to create new therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02), a galectin-3 inhibitor, which is in Phase 2b/3 clinical trial to prevent esophageal varices in patient with non-alcoholic steatohepatitis cirrhosis; and Phase 2 clinical trial for the treatment of liver fibrosis, as well as severe skin disease, and melanoma and he...

Industry: Biotechnology
Sector: Healthcare
Phone: 678 620 3186
Address:
4960 Peachtree Industrial Boulevard, Suite 240, Norcross, United States
Indibviduate1
Indibviduate1 Feb. 4 at 4:54 AM
0 · Reply
Indibviduate1
Indibviduate1 Feb. 4 at 3:27 AM
$GALT anyone else find it strange they haven’t replaced the director who resigned?
0 · Reply
BullsOnParade79
BullsOnParade79 Feb. 4 at 3:20 AM
$GALT @thePistolPete you should buy a few shares. I’m adding more here.
1 · Reply
Indibviduate1
Indibviduate1 Feb. 4 at 2:58 AM
0 · Reply
ThomasLD
ThomasLD Feb. 4 at 2:37 AM
$GALT Just don’t think about this company for a while and a big surprise will come sooner than you think. Go GALT. 🥇
0 · Reply
Indibviduate1
Indibviduate1 Feb. 4 at 2:22 AM
1 · Reply
Indibviduate1
Indibviduate1 Feb. 4 at 1:39 AM
$GALT the kol know the value of belapectin in this unmet need and they know how remarkable the results were in the most seriously ill group of patients. And by now they must know if this drug works better in combination with glpt-1. The us 2mg ppp results say it does. How long will a buyer wait?
1 · Reply
JBRUN
JBRUN Feb. 4 at 1:27 AM
$GALT lately in the AH trading is just about nothing to be mentioned, today something changed, we might have news in the morning
1 · Reply
SamGantVHee
SamGantVHee Feb. 4 at 12:21 AM
$GALT seems to be breaking out of the downtrend channel, let's see if it can keep it up. No point in fundamentals and technicals honestly. This will trade unexpectedly and erratically until we get news.
0 · Reply
Schuuultz
Schuuultz Feb. 3 at 11:40 PM
0 · Reply
Latest News on GALT
Clinical Progress Drives Galectin Shares Up Post-NAVIGATE Data

Dec 4, 2025, 8:42 AM EST - 2 months ago

Clinical Progress Drives Galectin Shares Up Post-NAVIGATE Data


Galectin Therapeutics to Present in Upcoming Conferences

Oct 14, 2022, 8:00 AM EDT - 3 years ago

Galectin Therapeutics to Present in Upcoming Conferences


Indibviduate1
Indibviduate1 Feb. 4 at 4:54 AM
0 · Reply
Indibviduate1
Indibviduate1 Feb. 4 at 3:27 AM
$GALT anyone else find it strange they haven’t replaced the director who resigned?
0 · Reply
BullsOnParade79
BullsOnParade79 Feb. 4 at 3:20 AM
$GALT @thePistolPete you should buy a few shares. I’m adding more here.
1 · Reply
Indibviduate1
Indibviduate1 Feb. 4 at 2:58 AM
0 · Reply
ThomasLD
ThomasLD Feb. 4 at 2:37 AM
$GALT Just don’t think about this company for a while and a big surprise will come sooner than you think. Go GALT. 🥇
0 · Reply
Indibviduate1
Indibviduate1 Feb. 4 at 2:22 AM
1 · Reply
Indibviduate1
Indibviduate1 Feb. 4 at 1:39 AM
$GALT the kol know the value of belapectin in this unmet need and they know how remarkable the results were in the most seriously ill group of patients. And by now they must know if this drug works better in combination with glpt-1. The us 2mg ppp results say it does. How long will a buyer wait?
1 · Reply
JBRUN
JBRUN Feb. 4 at 1:27 AM
$GALT lately in the AH trading is just about nothing to be mentioned, today something changed, we might have news in the morning
1 · Reply
SamGantVHee
SamGantVHee Feb. 4 at 12:21 AM
$GALT seems to be breaking out of the downtrend channel, let's see if it can keep it up. No point in fundamentals and technicals honestly. This will trade unexpectedly and erratically until we get news.
0 · Reply
Schuuultz
Schuuultz Feb. 3 at 11:40 PM
0 · Reply
Indibviduate1
Indibviduate1 Feb. 3 at 9:58 PM
$GALT I think it’s more likely that news has leaked. It always does.
2 · Reply
Belapectin
Belapectin Feb. 3 at 9:45 PM
$GALT from Gemini
0 · Reply
Belapectin
Belapectin Feb. 3 at 9:14 PM
$GALT I like this.
3 · Reply
Manonfire8
Manonfire8 Feb. 3 at 9:02 PM
$GALT according to Gemini; seems to be a catalyst for today. Any of the brains on can confirm?
2 · Reply
JBRUN
JBRUN Feb. 3 at 9:02 PM
$GALT volume at closing just under 300K
1 · Reply
Belapectin
Belapectin Feb. 3 at 8:56 PM
$GALT whats going on?
1 · Reply
History101
History101 Feb. 3 at 8:53 PM
$GALT glad i added below 3.07 today. GLTALs!!
0 · Reply
JBRUN
JBRUN Feb. 3 at 7:55 PM
$GALT anyone knows of a partner lined up or a buyer?
2 · Reply
kookiemonsteryum
kookiemonsteryum Feb. 3 at 7:41 PM
$GALT a y guesses to when type c meeting happens
3 · Reply
D_Coral
D_Coral Feb. 3 at 4:49 PM
0 · Reply
JollyAcorn2021
JollyAcorn2021 Feb. 3 at 3:38 PM
$GALT Total volume after one hour of trading today was 21,454. Unless it picks up, we are on crouse for a relatively low volume day of about 140K shares. They have apparently turned off the auto-shorting algorithm for today.
1 · Reply
vettebk
vettebk Feb. 3 at 3:07 PM
$GALT I still believe in belapectin. Time will tell all.
0 · Reply